170 related articles for article (PubMed ID: 22043910)
1. Alkylating antitumor drug mechlorethamine conceals a structured PrP domain and inhibits in vitro prion amplification.
Zhou X; Bi H; Wong J; Shimoji M; Wang Y; Yuan J; Xiao X; Wang GX; Zou WQ
J Toxicol Environ Health A; 2011; 74(22-24):1493-503. PubMed ID: 22043910
[TBL] [Abstract][Full Text] [Related]
2. Concealment of epitope by reduction and alkylation in prion protein.
Yuan J; Kinter M; McGeehan J; Perry G; Kneale G; Gambetti P; Zou WQ
Biochem Biophys Res Commun; 2005 Jan; 326(3):652-9. PubMed ID: 15596149
[TBL] [Abstract][Full Text] [Related]
3. Prion protein aggregation and fibrillogenesis in vitro.
Stöhr J
Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
[TBL] [Abstract][Full Text] [Related]
4. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
5. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
6. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
7. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
Yam AY; Gao CM; Wang X; Wu P; Peretz D
PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
[TBL] [Abstract][Full Text] [Related]
8. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
9. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
10. Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence.
Coleman BM; Nisbet RM; Han S; Cappai R; Hatters DM; Hill AF
Biochem Biophys Res Commun; 2009 Mar; 380(3):564-8. PubMed ID: 19285001
[TBL] [Abstract][Full Text] [Related]
11. The elusive intermediate on the folding pathway of the prion protein.
Jenkins DC; Sylvester ID; Pinheiro TJ
FEBS J; 2008 Mar; 275(6):1323-35. PubMed ID: 18279390
[TBL] [Abstract][Full Text] [Related]
12. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.
Saborio GP; Permanne B; Soto C
Nature; 2001 Jun; 411(6839):810-3. PubMed ID: 11459061
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
14. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
15. Towards cellular receptors for prions.
Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
[TBL] [Abstract][Full Text] [Related]
16. In vitro conversion and seeded fibrillization of posttranslationally modified prion protein.
Stöhr J; Elfrink K; Weinmann N; Wille H; Willbold D; Birkmann E; Riesner D
Biol Chem; 2011 May; 392(5):415-21. PubMed ID: 21476870
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of prion transmission].
Sakaguchi S
Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation.
Iwamaru Y; Shimizu Y; Imamura M; Murayama Y; Endo R; Tagawa Y; Ushiki-Kaku Y; Takenouchi T; Kitani H; Mohri S; Yokoyama T; Okada H
J Neurochem; 2008 Nov; 107(3):636-46. PubMed ID: 18717818
[TBL] [Abstract][Full Text] [Related]
19. Conformational polymorphism of wild-type and mutant prion proteins: Energy landscape analysis.
Levy Y; Becker OM
Proteins; 2002 Jun; 47(4):458-68. PubMed ID: 12001224
[TBL] [Abstract][Full Text] [Related]
20. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
